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Abstract
Depression is associated with a significant individual and social burden of disease. The European Health Interview Survey 
(EHIS) provides data that can be used to compare the situation in Germany to that of other European countries. Data 
was evaluated from 254,510 interviewees from Germany and 24 additional Member States of the European Union (EU). 
Depressive symptoms as defined by the Patient Health Questionnaire (PHQ-8) were used as an indicator of depression. 
The prevalence in Germany (9.2%) is higher than the European average (6.6%). However, when the severity of depression 
is taken into account, only the prevalence of mild depressive symptoms is higher (6.3% versus 4.1%). In Germany, young 
people display depressive symptoms more frequently (11.5% versus 5.2%) than older people (6.7% versus 9.1%). These 
results should be discussed against the backdrop of differences in age and social structure and point toward a need for 
prevention and provision of care targeting younger people in Germany, in particular.
 DEPRESSIVE SYMPTOMS · DEPRESSIVE SYMPTOM SEVERITY · SEX AND AGE · EUROPEAN COMPARISON 
Introduction
Depression is associated with a significant individual and 
social burden of disease [1-4]. A reduction in quality of life 
and productivity are not only observed in individuals with 
manifest depression, but also in people with depressive 
symptoms [1, 5]. Although depression has become a focus 
of national and European public health measures, an actu-
al comparison of the prevalence of depression in Germany 
with the other European countries is scarse [6]. Aiming at 
developing possible approaches for targeted national and 
European public health activities that go beyond the coun-
try-specific prevalence of depressive symptoms, this article 
also considers sex and age differences and the severity of 
depressive symptoms.
Indicator
In the European Health Interview Survey (EHIS), all Member 
States of the European Union (EU) collect data on health, 
healthcare, health determinants and the socioeconomic sit-
uation of their populations (Info box). The target group are 
people aged at least 15 years living in private households. A 
manual containing recommendations and guidelines on 
methodology and data collection is available to ensure a high 
degree of harmonisation among survey results [7]. Data for 
the second wave of EHIS (EHIS 2) was collected between 
2013 and 2015 and, on average, took eight months. During 
the EHIS 2 survey period, the EU had 28 Member States. The 
EHIS quality report [8] and the article by Hintzpeter et al. [9] 
in this issue present the methodology of EHIS 2 in more detail. 
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greater statistical uncertainty of the results. A statistically 
significant difference between groups can be assumed if 
the corresponding p-value is smaller than 0.05. Differences 
between the EU average and the individual EU Member 
States were assessed using regression analyses (with Ger-
many as the reference category). The analyses differenti-
ated between (1) the prevalence of depressive symptoms 
and (2) the severity of symptoms. To control for systematic 
differences between EU Member States, analyses were per-
formed in control of age, sex, education and income status 
and, moreover, was the clustering of individual data within 
each Member State taken into account.
In order to present the indicators more clearly, Figure 1 
does not provide individual values for each EU Member 
State; instead, it describes the minimum and maximum 
values from the EU countries that provide data. Figure 1 
also displays the average for the included EU Member 
States and the prevalence in Germany.
The analyses applied a weighting factor to account for 
each EU Member State proportionally according to the size 
of its population. In line with the recommendations by 
Eurostat, education was not used as a weighting factor for 
the comparison of European countries [11]. This leads to 
differences from previously reported German prevalences 
based on data from GEDA 2014/2015-EHIS [14]. In order to 
enable greater comparability of health indicators, values are 
standardised by age and sex in accordance with the revised 
European standard population (ESP) for 2013. This corrects 
for possible differences between the age structures found 
in the various countries and, therefore, enhances the com-
parability of health indicators [15]. The following analyses 
used the household indicator variable as a cluster variable.
In Germany, EHIS is carried out as part of health monitor-
ing at the Robert Koch Institute. EHIS 2 was integrated into 
the German Health Update (GEDA 2014/2015-EHIS) [10, 11]. 
A detailed description of the methodology applied in GEDA 
2014/2015-EHIS can be found in Lange et al. [11].
Depressive symptoms were assessed using a coun-
try-specific version of the internationally established 8-item 
Patient Health Questionnaire (PHQ-8) [12]. The PHQ-8 com-
prises symptoms of a major depression during the last two 
weeks in line with the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV, 4th edition [13]): depressed 
mood, diminished interest, significant weight loss or poor 
appetite, insomnia or hypersomnia, psychomotor agitation 
or retardation, fatigue or loss of energy, feelings of worth-
lessness or excessive or inappropriate guilt, diminished 
ability to think or concentrate. Each of these items was rated 
on a scale ranging from 0 (not at all), 1 (on individual days), 
2 (more than half of the days) to 3 (nearly every day). Answers 
are summarized to a sum score and values greater 10 indi-
cate a depressive symptomatology. Whereas values between 
10 and 14 indicate a ‘mild’ depressive symptomatology, val-
ues greater 14 indicate a ‘moderate to severe’ depressive 
symptomatology [12]. 
The findings on depressive symptoms are based on the 
answers provided by 254,510 participants (139,614 women, 
114,896 men) in the age groups 15 to 29 years, 30 to 44 
years, 45 to 64 years and ≥ 65 years. Twenty-five out of the 
28 EU Member States (excluding Belgium, the Netherlands 
and Spain) provided valid data.
Prevalences are stratified by sex and EU Member State. 
The precision of prevalences can be estimated based on 
95% confidence intervals (95% CI). A wide 95% CI indicates 
GEDA 2014/2015-EHIS  
(for international comparisons)
Data holder: Robert Koch Institute
Aims: To provide reliable information about the 
population’s health status, health behaviour and 
health care in Germany, with the possibility of a 
European comparison 
Method: Questionnaires completed on paper or 
online 
Population: People aged 15 years and above with 
permanent residency in Germany
Sampling: Registry office sample; randomly select-
ed individuals from 301 communities in Germany 
were invited to participate
Participants: 24,824 people (13,568 women, 11,256 
men)
Response rate: 27.6% 
Study period: November 2014 - July 2015 
More information in German is available at 
www.geda-studie.de and Lange et al. 2017 [11]
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in Bulgaria (3.5%), Luxemburg (3.8%), Portugal (3.2%), 
Hungary (3.0%) and the United Kingdom (3.3%). However, 
these differences are not statistically significant.
The Europe-wide collection of PHQ-8 data in EHIS 2 
enables a simultaneous comparison of the prevalence of 
depressive symptoms among individuals covering the adult 
life span for the first time. The results for Germany indicate 
a particularly high prevalence of depressive symptoms. In 
addition, findings from other German national surveys sug-
gest an increase of depressive symptoms [14] and the risk 
of depression faced by younger women, as well as depres-
sion-related impairments [16] over time. The increasing 
importance of depression is also substantiated by data 
from German healthcare provision [17]. The present results 
point toward a particular need for public health action in 
terms of prevention measures and provision of care in Ger-
many. Thereby, the risk of developing manifest depressive 
disorders could be reduced. 
Strengthening prevention and the treatment of depres-
sion has been a national health target since 2006 [18]. In 
Germany, working environments are considered as one 
starting point for prevention measures addressing (mild) 
depressive symptoms [19]. Following a decision by Germa-
ny’s Federal Labour Court in 2008, the ‘mental and psy-
chological integrity of workers and employees’ became a 
criterion in workplace hazard assessments (12 August 2008, 
9 AZR (case number for the appeal) 1117/06). Since the 
embodiment of paragraph 5 point 6 of the Occupational 
Safety and Health Act, ‘psychological stress at work’, in 
2013, the prevention of mental distress in workplaces and 
the consideration of mental health has gained more atten-
tion as a transversal issue in several social areas. Accord-
Results and discussion
The prevalence of depressive symptoms in Germany (9.2%) 
is higher than the European average (6.6%) and higher 
than in most EU Member States, with the exceptions of 
Luxemburg, Sweden and Portugal (Table 1).
In the majority of EU Member States, women are more 
frequently affected by depressive symptoms than men. In 
Germany, 10.8% of women show depressive symptoms 
while the prevalence of men is considerably lower with 7.6% 
(Table 1). Moreover, the average prevalence across the EU 
for both women (7.9%) and men (5.2%) is lower than in Ger-
many. Prevalences did not differ significantly between women 
and men in Finland, Ireland, Croatia, Luxemburg, Romania, 
Slovakia, Austria and the Czech Republic (Table 1).
In Germany, as well as in other EU Member States such 
as Ireland, Luxemburg and Sweden, adolescents and young 
adults (15- to 29-year-olds) show the highest prevalence of 
depressive symptoms. In Germany, the prevalence in this 
age group (11.5%) is significantly higher than the EU aver-
age (5.2%) (Figure 1). In other EU Member States such as 
Italy, Portugal and Romania, the prevalence is the highest 
among persons aged 65 and older (11.6%, 14.7% and 13.9%, 
respectively). The prevalence in this oldest age group 
(6.7%) is lower in Germany as compared to the EU aver-
age (9.1%).
As shown in Figure 1, the prevalence of mild depressive 
symptoms is higher in Germany (6.3%) than the EU aver-
age (4.1%) and represents the European peak value. Only 
Luxemburg has a comparably high prevalence (6.1%). 
Regarding the prevalence of moderate to severe depressive 
symptoms, Germany (2.9%) is close to the EU average 
(2.5%). Higher prevalences than in Germany can be found 
Info box 
European Health Interview Survey (EHIS)
The European Core Health Indicators (ECHI) 
were jointly developed by EU Member States and 
international organisations, taking into account 
scientific and health policy requirements. The 
indicators provide a framework in European 
health reporting for population-based health sur-
veys and analyses, and health care provision at 
the European and national level. The European 
Health Interview Survey (EHIS) is a key element 
in this regard. The first EHIS wave (EHIS 1), 
which was not mandatory, was conducted 
between 2006 and 2009. 17 Member States and 
two non-EU countries participated in EHIS 1. Par-
ticipation in the second wave of EHIS (EHIS 2), 
which was conducted between 2013 and 2015 in 
all EU Member States (as well as in Iceland, Nor-
way and Turkey) was legally binding and is based 
on Commission Regulation (EU) No 141/2013 of 
19 February 2013. It provides essential informa-
tion about the ECHI indicators. In Germany, 
EHIS is carried out as part of health monitoring 
at the Robert Koch Institute. During the EHIS 2 
survey period, the EU had 28 Member States.
Further information is available at:
https://ec.europa.eu/eurostat/web/microdata/
european-health-interview-survey
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ingly, the European Joint Action for Mental Health and 
Wellbeing defined ‘Mental Health in all Policies’ and ‘Men-
tal Health at Workplaces’ as two out of five action fields for 
intervention.
However, when stratified by severity, the differences 
between Germany and the EU average only apply to mild 
depressive symptoms. One possible explanation, beyond 
potential differences in morbidity, refers to differences in 
health competence regarding mental well-being (‘mental 
health literacy’ [20]). Varying levels of mental health liter-
acy are associated with differences in willingness to report 
mental health symptoms, and, therefore, can influence the 
Table 1 
Age standardised prevalence of depressive 
symptoms (PHQ-8 ≥ 10 points) during the last 
two weeks by sex and EU Member State 
(n=139,614 women, n=114,896 men)
Source: EHIS 2 (2013-2015)
The prevalence of depressive 
symptoms in Germany is 
higher (9.2%) than the  
European average (6.6%).
Member State Women Men Total
% (95% CI) % (95% CI) % (95% CI)
Austria 5.1 (4.5-5.8) 3.4 (2.8-4.2) 4.3 (3.8-4.8)
Bulgaria 8.0 (7.1-9.1) 6.0 (5.1-7.1) 7.1 (6.3-7.9)
Croatia 3.4 (2.8-4.1) 3.4 (2.8-4.3) 3.4 (2.9-4.0)
Cyprus 5.2 (4.3-6.3) 3.0 (2.3-3.9) 4.1 (3.5-4.9)
Czech Republic 3.4 (2.8-4.1) 2.0 (1.5-2.7) 2.7 (2.3-3.2)
Denmark 9.5 (8.4-10.6) 5.3 (4.4-6.3) 7.4 (6.7-8.2)
Estonia 8.0 (7.0-9.0) 5.0 (4.1-6.0) 6.6 (5.9-7.3)
Finland 6.4 (5.6-7.3) 5.7 (4.8-6.8) 6.0 (5.4-6.7)
France 9.0 (8.3-9.8) 5.2 (4.6-5.8) 7.2 (6.7-7.7)
Germany1 10.8 (10.2-11.4) 7.6 (7.1-8.2) 9.2 (8.8-9.6)
Greece 3.8 (3.3-4.5) 2.5 (1.9-3.3) 3.2 (2.8-3.7)
Hungary 9.6 (8.7-10.7) 7.1 (6.1-8.3) 8.5 (7.7-9.3)
Ireland 8.8 (7.8-10.0) 6.6 (5.7-7.7) 7.8 (7.0-8.5)
Italy 5.6 (5.2-6.0) 3.5 (3.2-3.9) 4.6 (4.3-4.9)
Latvia 5.8 (5.0-6.6) 3.3 (2.7-4.1) 4.7 (4.2-5.3)
Lithuania 4.1 (3.5-4.8) 2.3 (1.7-3.1) 3.3 (2.9-3.8)
Luxemburg 11.7 (10.3-13.2) 8.2 (7.0-9.6) 10.0 (9.0-11.0)
Malta 4.4 (3.6-5.4) 2.2 (1.6-3.0) 3.3 (2.8-3.9)
Poland 5.5 (5.0-6.0) 4.0 (3.5-4.5) 4.8 (4.4-5.1)
Portugal 12.9 (11.9-13.9) 4.7 (4.1-5.4) 9.1 (8.5-9.7)
Romania 5.1 (4.6-5.6) 4.7 (4.2-5.4) 4.9 (4.5-5.3)
Slovakia 3.4 (2.8-4.2) 2.3 (1.7-3.1) 2.9 (2.4-3.4)
Slovenia 7.3 (6.4-8.2) 4.0 (3.2-4.8) 5.6 (5.1-6.3)
Sweden 11.2 (10.0-12.4) 6.5 (5.7-7.4) 8.8 (8.1-9.6)
United Kingdom 8.6 (7.9-9.3) 6.1 (5.5-6.8) 7.4 (6.9-7.9)
EU 7.9 (7.7-8.1) 5.2 (5.1-5.4) 6.6 (6.5-6.8)
1 Statistically significant differences: total Germany vs. EU (p < 0.01), women Germany vs. EU (p < 0.01), men Germany vs. EU (p < 0.01)
CI = Confidence interval, EU = Average of the EU Member States for which data is available (excluding Belgium, the Netherlands and Spain)
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responses that participants provide in the respective coun-
tries [21-23]. Increasing knowledge and improved under-
standing of the symptoms of mental health problems in 
the population may also lead to greater sensitivity towards 
depressive symptoms [22]. 
Furthermore, the present results indicate that in Ger-
many – as well as in most of the other EU Member States 
– women are affected more frequently by depressive symp-
toms than men. This difference between the sexes is con-
sistent with other international results [24, 25]. Beside bio-
logical factors, the higher prevalence of women is currently 
discussed in terms of cumulating psycho-social stressors. 
In addition, particularly German young adults show a 
higher prevalence of depressive symptoms than the EU 
average. Results are also in line with previous findings of 
a higher prevalence of depressive symptoms among older 
adults in southern European nations such as Italy, Portu-
gal and Romania as compared to Germany [26]. Possible 
explanations include regional differences in social struc-
ture such as education, income and unemployment rate 
[27, 28], health care availability, for example an ‘over- 
diagnosis’ of elderly people [29], and cultural differences 
such as (self)stigmatisation [30]. Future surveys also need 
to consider possible differences in data collection method-
ology [8].
At the national level, differences in the frequency of 
depressive symptoms have already been discussed against 
the backdrop of a region’s age and social structure, the 
spatial distribution of risk and protective factors, as well 
as the degree of urbanisation [14]. However, the reason 
why especially young adults show such a high prevalence 
in Germany and the health policy measures and contexts 
that could or should be used to reach them, remains an 
open question – particularly, because healthcare services 
in Germany identified depression rather often among the 
elderly [31].
Figure 1 
Age standardised prevalence of depressive 
symptoms during the last two weeks by age 
and severity (mild depressive symptoms: 
PHQ-8 10-14 points; moderate to severe 
depressive symptoms: PHQ-8 >14 points)
Source: EHIS 2 (2013-2015)
Significant differences 
between Germany and the 
EU average pertain to the 
prevalence of mild, but not 
moderate or severe  
depressive symptoms.






15-29 years  
Age group
GermanyEUlowest to highest value
Proportion (%)
0             3             6                             9                     12               15                    18 
EU = Average of the EU Member States for which data is available (excluding Belgium, the Netherlands and Spain)
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Equally to the majority of 
other EU Member States, 
depressive symptoms in 
Germany are more frequent 
among women as compared 
to men.
Depressive symptoms are 
more frequent among young 
people in Germany than the 
EU average (11.5% compared 
to 5.2%) and less frequent 
among older people than the 
EU average (6.7% compared 
to 9.1%).
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